Condition

Stage III Pancreatic Cancer AJCC v8

ClinicalTrials.gov condition label

Clinical trials12
Recruiting1
Common interventions25
Lead sponsors shown6

Clinical trials

12 shown
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid TumorsNCT05733000 · 2023-03-08
RECRUITING
A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic CancerNCT06630325 · 2025-06-24
TERMINATED
SMMART Adaptive Clinical Treatment (ACT) TrialNCT05238831 · 2023-01-30
WITHDRAWN
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic CancerNCT04514497 · 2021-10-20
ACTIVE_NOT_RECRUITING
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal CancerNCT04673448 · 2021-10-18
ACTIVE_NOT_RECRUITING
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair VariationsNCT04550494 · 2021-04-26
ACTIVE_NOT_RECRUITING
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialNCT03878524 · 2020-04-01
TERMINATED
A Phase I Study of SOR-C13 in Patients With Advanced Solid TumorsNCT03784677 · 2019-07-29
COMPLETED
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV CancerNCT04067960 · 2019-06-06
COMPLETED
IACS-010759 in Advanced CancersNCT03291938 · 2017-11-13
COMPLETED
Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal CancerNCT02983578 · 2017-03-02
ACTIVE_NOT_RECRUITING
M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryNCT02595931 · 2016-07-22
ACTIVE_NOT_RECRUITING

Common interventions

Biospecimen CollectionPROCEDURE9Computed TomographyPROCEDURE5Magnetic Resonance ImagingPROCEDURE4BiopsyPROCEDURE3Quality-of-Life AssessmentOTHER3AbemaciclibDRUG2BevacizumabBIOLOGICAL2Biopsy ProcedurePROCEDURE2CapecitabineDRUG2CarboplatinDRUG2CobimetinibDRUG2DurvalumabBIOLOGICAL2EntrectinibDRUG2FluorouracilDRUG2Irinotecan HydrochlorideDRUG2LetrozoleDRUG2Nab-paclitaxelDRUG2NiraparibDRUG2OlaparibDRUG2PalbociclibDRUG2PertuzumabBIOLOGICAL2Trastuzumab EmtansineBIOLOGICAL2VemurafenibDRUG2VismodegibDRUG2AbirateroneDRUG1

Trial status mix

ACTIVE_NOT_RECRUITING5
COMPLETED3
TERMINATED2
RECRUITING1
WITHDRAWN1

Phase mix

PHASE16
PHASE24
EARLY_PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.